Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 20, 2023 07:00 ET | Source: Orphalan

Orphalan announces US commercial launch of Cuvrior™ for the treatment of Wilson disease

Cuvrior™ now available in the US for the treatment of adult patients with stable Wilson disease who are de-coppered and tolerant to penicillamine — Oral administration offers dosing flexibility and...